Ultrasound Breakthrough Enhances Brain Cancer Treatment

New technique using ultrasound and microbubbles shows promise in delivering chemotherapy and immunotherapy for glioblastoma patients.

Researchers at Northwestern Medicine used ultrasound to penetrate the blood-brain barrier, allowing drug delivery.
The method combines low doses of chemotherapy and immunotherapy to boost immune system recognition of cancer cells.
A clinical trial has been launched to evaluate the safety and effectiveness of the new approach in prolonging survival.
Initial studies in both mice and humans indicate improved drug penetration and immune response against glioblastoma.
This approach may overcome previous challenges in treating glioblastoma due to poor drug delivery to the brain.